This post was originally published on this sitehttps://i-invdn-com.akamaized.net/news/LYNXNPEC0Q1B5_M.jpg
Thermo Fisher Scientific announced earnings per share of $2.94 on revenue of $6.23B. Analysts polled by Investing.com anticipated EPS of $2.81 on revenue of $6.17B. That with comparison to EPS of $2.81 on revenue of $6.13B in the same period a year before. Thermo Fisher Scientific had reported EPS of $3.55 on revenue of $6.83B in the previous quarter. Analysts are expecting EPS of $2.91 and revenue of $6.1B in the upcoming quarter.
Thermo Fisher Scientific shares are down 1% from the beginning of the year , still down 6.61% from its 52 week high of $342.26 set on January 22. They are outperforming the S&P 500 which is down 15.66% year to date.
Thermo Fisher Scientific’s report follows an earnings beat by J&J on April 14, who reported EPS of $2.3 on revenue of $20.69B, compared to forecasts EPS of $2.02 on revenue of $19.73B.
Abbott Labs had beat expectations on April 16 with first quarter EPS of $0.65 on revenue of $7.73B, compared to forecast for EPS of $0.59 on revenue of $7.44B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar